186 related articles for article (PubMed ID: 31591939)
1. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
Wu Q; Ma J; Meng W; Hui P
Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
[TBL] [Abstract][Full Text] [Related]
2. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
Liang Y; Zhang CD; Zhang C; Dai DQ
Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
[TBL] [Abstract][Full Text] [Related]
3. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
Tian Y; Wang YR; Jia SH
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7307-7313. PubMed ID: 31539117
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
Li D; Tang X; Li M; Zheng Y
J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
Jia P; Wei E; Liu H; Wu T; Wang H
IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
[TBL] [Abstract][Full Text] [Related]
7. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T
Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region.
Zhao H; Xu Q
J Cell Mol Med; 2020 Nov; 24(21):12572-12584. PubMed ID: 32951317
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.
Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L
FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT.
Zhang W; Zhai Y; Wang W; Cao M; Ma C
Gene; 2018 Dec; 678():377-383. PubMed ID: 30118890
[TBL] [Abstract][Full Text] [Related]
14. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
Zhou C; An N; Cao C; Wang G
J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer.
Luo J; Xiang H
Bioengineered; 2021 Dec; 12(1):3101-3112. PubMed ID: 34181498
[TBL] [Abstract][Full Text] [Related]
19. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer.
Dong Y; Li X; Lin Z; Zou W; Liu Y; Qian H; Jia J
J Exp Clin Cancer Res; 2019 Dec; 38(1):502. PubMed ID: 31870402
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA
Xie F; Xie G; Sun Q
Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
